The American Cancer Society published a report in their journal called CANCER that stated, “The consumption of aspirin helps in the prevention of breast cancer in some cases” thereby helping in breast cancer treatment.
— CNN (@CNN) October 4, 2018
Each patient responds differently to breast cancer treatment therapy. The reason is unclear. However, few suggest that unique gene sequences and chemical modifications of DNA play a major role.
Marilie Gammon and Tengteng Wang at the University of North Carolina in Chapel Hill questioned: “Is DNA methylation influenced by the consumption of aspirin breast cancer patients?”
To find an answer to this question, they examined the process of DNA methylation in breast tumor tissues. This is the very first time, the effect of DNA methylation and aspirin is examined. This will further reveal the mortality in patients suffering from breast cancer.
Study statistics and results-
The study was conducted with the help of 1266 women. All the women were patients of breast cancer and diagnosed in the year 1996-1997. Among these women, 476 women lost their lives while 202 women lost their battles to breast cancer in 2014.
The statistics reveal that the consumers of aspirin, have a significantly lower risk of death, due to breast cancer. In other words, a higher mortality rate is observed in women who consumed aspirin.
Researchers revealed aspirin led to DNA methylation
Dr. Wang revealed The DNA methylation profile can be used as a potential modifier; this can possibly provide newer insights into the field of a breast cancer diagnosis.
Aspirin, breast cancer blood test, Boris Johnson's NHS plans and bowel cancer rates in young people were in the headlines last week. For a round-up of the week's cancer news visit: https://t.co/IK1XvbvQsf
— CRUK_Health professionals (@CRUKHCPs) August 6, 2019
If these results are cent percent confirmed, it may significantly affect clinical decision-makers.
Aspirin: Low-cost therapy in breast cancer treatment
Perhaps, by classifying subgroups of patients. In fact, this study can help improve the strategies of risk reduction which will further increase survival in various breast cancer cases.
Kristen Malecki from the University of Wisconsin-Madison revealed aspirin can be proved to be a low-cost therapy in breast cancer treatments.
DNA methylation can be the future of breast cancer treatment.